home · filing · 0001438133-22-000163
8-K filed June 16, 2022, 7:59 PM ET
ticker TNDM
CIK 0001438133
leadership
confidence high
sentiment neutral
materiality 0.35
Tandem Diabetes appoints Myoung Cha and Joao Malagueira to board
TANDEM DIABETES CARE INC
Myoung Cha elected Class III director effective June 15, 2022; will serve on Compensation Committee.
Cha is President & CSO at Carbon Health; previously Head of Health Strategic Initiatives at Apple.
Joao Malagueira elected Class I director effective June 15, 2022; will serve on Audit Committee.
Malagueira is VP for three divisions at Hologic; 25+ years experience in diabetes and medical devices.
Board size increased from nine to ten directors; both new directors are independent under Nasdaq rules.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-06-15
Filed June 16, 2022, 7:59 PM ET
elected Joao Malagueira, age 56, to serve as a Class I director on the Board
Effective 2022-06-15
Filed June 16, 2022, 7:59 PM ET
elected Myoung Cha, age 45, to serve as a Class III director on the Board
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joao Malagueira was elected as Director at TANDEM DIABETES CARE INC.
Action elected
Role Director
Exact text from the filing
elected Joao Malagueira, age 56, to serve as a Class I director on the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Myoung Cha was elected as Director at TANDEM DIABETES CARE INC.
Action elected
Role Director
Exact text from the filing
elected Myoung Cha, age 45, to serve as a Class III director on the Board
View on SEC.gov
Source: SEC EDGAR
accession 0001438133-22-000163
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.